QBX-28497-60118 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-26
Registered in v-safe
2020-12-26
Dose 1 — Pfizer-BioNTech
2020-12-26
Health check-in — day 0, dose 1
Feeling: Good · None

Adult check-in
2020-12-27
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2020-12-28
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2020-12-29
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2020-12-30
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Fatigue or tiredness

Adult check-in
2020-12-31
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-01
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-02
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2021-01-09
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-01-16
Dose 2 — Pfizer-BioNTech
2021-01-16
Health check-in — day 0, dose 2
Feeling: Good · None

Adult check-in
2021-01-17
Survey response — days 1–6 daily, dose 2
MedDRA: Decreased appetite — Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Free text: Decreased appetite

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-17
Report sent to call center — days 1–6 daily, dose 2
Be unable to do your normal daily activities

1 call case(s)
2021-01-18
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Headache

Adult check-in
2021-01-19
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-01-20
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-01-21
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-01-22
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-01-23
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-01-30
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-02-06
Survey response — day 21, dose 2
MedDRA: Lymphadenopathy — Feeling: Good

Free text: Enlarged lymph node in right axilla

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-13
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-02-20
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-02-27
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-04-18
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-07-17
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2022-01-16
Health check-in — 12 months, dose 2
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-26	Pfizer-BioNTech
2	2021-01-16	Pfizer-BioNTech

Call center

1 call center case

1 priority 2/3 (triaged and no follow up)

See the call center timeline

Free text

Release 2 — days 1–6 daily, dose 2

2021-01-17

Systemic reaction (other): Decreased appetite

Release 3 — day 21, dose 2

2021-02-06

Symptoms: Enlarged lymph node in right axilla

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Lymphadenopathy	✓	✓	✓
SRO	Decreased appetite	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release